Correction: MicroRNA-based integrated diagnosis and therapy for GBM: current status and advances
-
By
-
Ye Chen
-
Huiyi Liu
-
Peipei Yuan
-
Yongqi Li
-
Changqiong Xu
-
Ran Li
-
Jibing Chen
-
Fasheng Wu
-
June 24, 2026
-
Clinical Scorecard: Update: Integrated Diagnosis and Treatment Approaches Using MicroRNA for Glioblastoma: Recent Developments and Current Insights
At a Glance
| Category | Detail |
|---|
| Condition | Glioblastoma |
| Key Mechanisms | MicroRNA involvement in diagnosis and therapy |
| Target Population | Patients with glioblastoma |
| Care Setting | Oncology and neurology clinics |
Key Highlights
- MicroRNAs play a crucial role in glioblastoma pathology.
- Recent advancements in integrated diagnosis and treatment approaches.
- Emphasis on upregulated miRNAs in glioblastoma.
Guideline-Based Recommendations
Diagnosis
- Utilize microRNA profiles for improved diagnostic accuracy.
Management
- Incorporate microRNA-targeted therapies in treatment plans.
Monitoring & Follow-up
- Regular assessment of microRNA levels to evaluate treatment response.
Risks
- Potential side effects associated with microRNA-based therapies.
Patient & Prescribing Data
Individuals diagnosed with glioblastoma.
MicroRNA-targeted therapies may enhance treatment efficacy.
Clinical Best Practices
- Integrate microRNA analysis in routine glioblastoma management.
Related Resources & Content
